Cumulus Neuroscience has been given the clearance by the US Food and Drug Administration (FDA) and the company says this will accelerate treatments for neuropsychiatric and neurodegenerative disorders.
Cumulus Neuroscience has been given the clearance by the US Food and Drug Administration (FDA) and the company says this will accelerate treatments for neuropsychiatric and neurodegenerative disorders.
Cumulus Neuroscience has been granted $510,000 clearance by the US Food and Drink Administration (FDA) and the company says this will accelerate treatments for neuropsychiatric and neurodegenerative disorders.
Joint replacement technology company Formus Labs has earned 510(k) clearance from the FDA for its image processing software for hip replacement preoperative planning.